Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis.

about

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis.

Item

http://www.wikidata.org/entity/Q41852421

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Neoadjuvant chemoradiation ver ...... ective single center analysis.

@en

type

Item

label

Neoadjuvant chemoradiation ver ...... ective single center analysis.

@en

prefLabel

Neoadjuvant chemoradiation ver ...... ective single center analysis.

@en

P1476

Neoadjuvant chemoradiation ver ...... ective single center analysis.

@en

P2093

Björn Schulze

http://www.w3.org/2001/XMLSchema#string

Christian Weiss

http://www.w3.org/2001/XMLSchema#string

Claus Rödel

http://www.w3.org/2001/XMLSchema#string

Dominik Bergis

http://www.w3.org/2001/XMLSchema#string

Guido Woeste

http://www.w3.org/2001/XMLSchema#string

Jörg Trojan

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction.

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Adenocarcinoma of the stomach: a review of 35 years and 1,710 cases.

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

P304

534-540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2013.1709

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wolf Otto Bechstein

Panagiotis Balermpas

P577

2013-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259608845

http://www.w3.org/2001/XMLSchema#string

P698

24396483

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

chemoradiotherapy

P932

3881691

http://www.w3.org/2001/XMLSchema#string